Whole-Body Imaging of Bone Marrow

被引:22
作者
Schmidt, Gerwin P. [1 ]
Reiser, Maximilian F. [1 ]
Baur-Melnyk, Andrea [1 ]
机构
[1] Univ Munich, Dept Clin Radiol, D-81377 Munich, Germany
关键词
Whole body; bone marrow; magnetic resonance imaging; positron emission tomography; computed tomography; POSITRON-EMISSION-TOMOGRAPHY; LANGERHANS CELL HISTIOCYTOSIS; CLINICAL STAGING SYSTEM; MULTIDETECTOR ROW-CT; MULTIPLE-MYELOMA; BREAST-CANCER; FDG-PET; CONVENTIONAL RADIOGRAPHY; SKELETAL METASTASES; COMPUTED-TOMOGRAPHY;
D O I
10.1055/s-0029-1220883
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
For bone marrow screening, multimodality algorithms including conventional radiographs, bone scintigraphy, multislice computed tomography CT (MS-CT) scan, and dedicated magnetic resonance imaging (MRI) are widely established in clinical routine. Although radiographs are used as a basic imaging procedure for clarification of suspected focal bone pathologies, low sensitivity has been reported for the detection of limited osteolytic bone marrow destruction. Therefore, skeletal scintigraphy often is used as a more sensitive and integrated method in patients with suspected malignant bone marrow disease. MS-CT scan is the method of choice in the assessment of bone stability and allows for evaluation of fracture risk. Hybrid imaging concepts, such as positron emission tomography-computed tomography (PET-CT) scan, have been established as an effective tool for the detection of skeletal metastases, using the. additional metabolic information of a PET scan for the assessment of tumor viability and therapy response. MRI is an imaging technique that allows direct visualization of bone marrow components with high spatial resolution. The unique soft-tissue contrast of MRI enables precise assessment of bone marrow infiltration before osteolytic changes become visible in MS-CT or metabolic changes occur in bone scintigraphy or a PET scan. Furthermore it can depict tumor expansion into adjacent paraosseous structures, such as the spinal canal. The development of multichannel whole-body MRI (WB-MRI) systems has enabled bone marrow screening without use of ionizing radiation at high diagnostic accuracy. Parallel imaging techniques in combination with global matrix coil concepts, as well as the introduction of high-field whole-body scanners, have substantially reduced acquisition times without compromises in spatial resolution. WB-MRI has successfully been applied for screening of bone metastases and hematologic bone marrow diseases, like multiple myeloma, lymphoma, and histiocytosis X. Furthermore, it has recently been proposed for the assessment of primarily benign bone diseases predisposing for malignancy (e.g., multiple cartilaginous exostoses). This article provides an overview of state-of-art whole-body imaging of the bone marrow and highlights present and potential future applications, especially in the field of WB-MRI.
引用
收藏
页码:120 / 133
页数:14
相关论文
共 71 条
[1]   The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis [J].
Bastiaannet, E ;
Groen, H ;
Jager, PL ;
Cobben, DCP ;
van der Graaf, WTA ;
Vaalburg, W ;
Hoekstra, HJ .
CANCER TREATMENT REVIEWS, 2004, 30 (01) :83-101
[2]   MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration [J].
Baur, A ;
Stabler, A ;
Bartl, R ;
Lamerz, R ;
Scheidler, J ;
Reiser, M .
SKELETAL RADIOLOGY, 1997, 26 (07) :414-418
[3]   Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon? [J].
Baur, A ;
Stäbler, A ;
Nagel, D ;
Lamerz, R ;
Bartl, R ;
Hiller, E ;
Wendtner, C ;
Bachner, F ;
Reiser, M .
CANCER, 2002, 95 (06) :1334-1345
[4]  
Baur-Melnyk A, 2004, RADIOLOGE, V44, P874, DOI 10.1007/s00117-004-1103-z
[5]   Whole-body MRI versus whole-body MDCT for staging of multiple myeloma [J].
Baur-Melnyk, Andrea ;
Buhmann, Sonja ;
Becker, Christoph ;
Schoenberg, Stefan Oswald ;
Lang, Nicola ;
Bartl, Reiner ;
Reiser, Maximilian Ferdinand .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) :1097-1104
[6]  
BEHESHTI M, 2008, EUR J NUCL MED 0515
[7]   Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases [J].
Brauck, Katja ;
Zenge, Michael O. ;
Vogt, Florian M. ;
Quick, Harald H. ;
Stock, Frank ;
Trarbach, Tanja ;
Ladd, Mark E. ;
Barkhausen, Joerg .
RADIOLOGY, 2008, 246 (03) :910-916
[8]   Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study [J].
Bristow, A. R. ;
Agrawal, A. ;
Evans, A. J. ;
Burrell, H. C. ;
Cornford, E. J. ;
James, J. J. ;
Hamilton, L. ;
Robertson, J. F. R. ;
Chan, S. Y. ;
Lawton, P. A. ;
Cheung, K. L. .
BREAST, 2008, 17 (01) :98-103
[9]   Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis [J].
Chassang, Madleen ;
Grimaud, Anne ;
Cucchi, J. M. ;
Novellas, Sebastien ;
Amoretti, Nicolas ;
Chevallier, Patrick ;
Bruneton, Jean Noeel .
CLINICAL IMAGING, 2007, 31 (04) :225-227
[10]   Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy - a feasibility study [J].
Chow, E ;
Holden, L ;
Rubenstein, J ;
Christakis, M ;
Sixel, K ;
Vidmar, M ;
Finkelstein, J ;
Hayter, C ;
Loblaw, A ;
Wong, R ;
Szumacher, E ;
Danjoux, C .
RADIOTHERAPY AND ONCOLOGY, 2004, 70 (03) :291-294